Phan, Céline http://orcid.org/0000-0001-7315-9600
Beneton, Nathalie
Delaunay, Juliette
Reguiai, Ziad
Boulard, Claire
Fougerousse, Anne-Claire
Cinotti, Elisa
Romanelli, Marco
Mery-Bossard, Laure
Thomas-Beaulieu, Domitille
Parier, Josiane
Maccari, François
Chaby, Guillaume
Bastien, Marie
Begon, Edouard
Samimi, Mahtab
Prignano, Francesca
Beauchet, Alain
Mahé, Emmanuel
Perrot, Jean-Luc
Ruer-Mulard, Mireille
Jacobzone, Caroline
Quiles-Tsimaratos, Nathalie
Descamps, Vincent
Steff, Maud
Bilan, Paul
Vermersch-Langlin, Annie
Kemula, Mathilde
Amazan, Emmanuelle
Kupfer-Bessaguet, Ingrid
Cottencin, Anne-Caroline
Livideanu, Bulai
Gottlieb, Jeremy
,
Article History
First Online: 21 July 2020
Compliance with ethical standards
:
: None.
: Other authors declare no conflicts of interest concerning this article.
: N. Beneton has paid activities as a consultant, advisor, or speaker for Abbvie, Celgene, Leo Pharma, Lilly, Janssen Cilag, Novartis, Pfizer, and UCB; J. Delaunay for Abbvie, Leo Pharma, Novartis, and Janssen Cilag; Z. Reguiai for Celgene, Janssen Cilag, Pfizer, Abbvie, Leo Pharma, Lilly, UCB, Medac, MSD, and Novartis; C. Boulard for Novartis, Abbvie, and Celgene; A.-C. Fougerousse for Novartis, Abbvie, Pfizer, Lilly, Celgene, and Janssen Cilag; L. Méry-Brossard for Abbvie, Leo Pharma, Novartis, Celgene, and Janssen Cilag; D. Thomas-Beaulieu for Novartis, Abbvie, Janssen Cilag, Lilly, Leo Pharma and Celgene; J. Parier for Janssen Cilag, Novartis, Celgene, and Leo Pharma; E. Mahé for Abbvie, Amgen, Janssen Cilag, Celgene, Leo Pharma, Lilly, Novartis, and Pfizer.